| 000 | 01051 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250513122244.0 | ||
| 264 | 0 | _c19970731 | |
| 008 | 199707s 0 0 eng d | ||
| 022 | _a0033-3182 | ||
| 024 | 7 |
_a10.1016/S0033-3182(97)71447-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBhandary, A N | |
| 245 | 0 | 0 |
_aBuspirone in the management of disruptive behaviors due to Huntington's disease and other neurological disorders. _h[electronic resource] |
| 260 |
_bPsychosomatics _c |
||
| 300 |
_a389-91 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBuspirone _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHuntington Disease _xpsychology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMental Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aSerotonin Receptor Agonists _xadministration & dosage |
| 700 | 1 | _aMasand, P S | |
| 773 | 0 |
_tPsychosomatics _gvol. 38 _gno. 4 _gp. 389-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0033-3182(97)71447-6 _zAvailable from publisher's website |
| 999 |
_c9197712 _d9197712 |
||